Dynamic risk stratification for predicting the recurrence in differentiated thyroid cancer

Area of Science:

• Endocrinology
• Oncology
• Nuclear Medicine

Background:

• Differentiated thyroid carcinoma (DTC) management requires accurate risk stratification for optimal patient outcomes.
• Initial risk classification, such as the American Thyroid Association (ATA) system, may not fully capture long-term disease trajectories.

Purpose of the Study:

• To evaluate the predictive capability of the dynamic risk stratification (DRS) system in a large cohort of DTC patients.
• To compare the efficacy of DRS with the ATA classification in predicting recurrent or persistent disease.

Main Methods:

• Retrospective analysis of 2184 DTC patients treated with radioiodine ablation post-thyroidectomy (1998-2014).
• Initial risk assessment using the ATA classification.
• Second-year dynamic risk stratification (DRS) performed.
• Comparison of ATA and DRS classifications against clinical outcomes.

Main Results:

• DRS reclassified over half (73.2%) of initially high-risk ATA patients to a lower-risk category.
• A small proportion (6.4%) of initially low-risk ATA patients were categorized as high-risk by DRS.
• Combined ATA and DRS risk assessment showed statistically significant predictive value for recurrent/persistent disease (P<0.005).

Conclusions:

• The dynamic risk stratification (DRS) system is a valuable addition to initial risk assessment in DTC.
• DRS aids in identifying patients who may not require prolonged, intensive follow-up, optimizing resource allocation.